Mr. David Kennedy joins Girindus as Director of Operations; Dr. Kathryn Ackley assumes leadership of Project Management

CINCINNATI--(Business Wire)--
Girindus America, Inc., a service provider to the pharmaceutical industry and a
leading manufacturer of therapeutic oligonucleotides, is pleased to announce
that Mr. David Kennedy has joined Girindus as Director of Operations. Mr.
Kennedy will report directly to Dr. F. Mark Laskovics, President and COO. Mr.
Kennedy will lead the Oligonucleotide, Small Molecule and Radiochemistry
operations. Mr. Kennedy brings to Girindus 30 years of Active Pharmaceutical
Ingredient (API) production experience in both the process validation and
commercial manufacturing areas. 'We are very pleased to have someone of David's
caliber and experience level leading our Operations Team', said Dr. Laskovics.
'David's addition enforces Girindus' technical competence and capability to
develop and execute commercial manufacturing programs.'

Mr. Kennedy received his B.S. Degree in Chemical Engineering at Clarkson
University in Potsdam, NY. Previously, he worked for Pfizer in the areas of
process engineering, bio-process development, commercial API production, and
production of sterile injectables.

In a related move, Dr. Kathryn Ackley has assumed leadership of Girindus'
Project Management group. In her new role, Dr. Ackley will manage the commercial
aspects of manufacturing programs; she will be the main interface between
clients and Girindus' operating and commercial groups. 'Kathy has the unique
skills to successfully bridge the technical and commercial interface', said Dr.
Laskovics. 'She has led both the Analytics and Operations groups, while playing
a key role in supporting the Sales Function.'

Dr. Ackley earned a Bachelor's degree in Chemistry from the University of
Kentucky and both a Master's and a Ph.D. degree in Analytical Chemistry from the
University of Cincinnati. She joined Girindus in 2001 as an Analytical Chemist
and has taken on positions of increasing responsibility. She became Section Head
of the Analytics Group in 2003, Production Manager in 2006 and Director of
Operations in 2008. Dr. Ackley was a 2006 recipient of the Solvay President's
Award for Excellence.

About Girindus

Girindus (www.girindus.com), a member of Solvay Organics is a global provider of
innovative drug actives and intermediates under cGMP through all clinical phases
to commercialization. Girindus is a recognized leader in manufacturing
Oligonucleotide therapeutics.

Sprache: Deutsch

Unternehmen: Girindus AG Buchenallee 20 51427 Bergisch Gladbach Deutschland
Internet: www.girindus.com

Girindus AG
Investor Relations
Markus Georgi
T: +49 2204 / 926 900
F: +49 2204 / 926 990
mgeorgi@girindus.com

Copyright Business Wire 2009